Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb Study of CT-P27 in Acute Uncomplicated Influenza A Infection
KCT0002211Phase 2Recruiting
- Sponsor
- Celltrion
- Start
- Dec 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of CT-P27 in Influenza A infection, sponsored by Celltrion. Started Dec 2016; status: recruiting.
02
Drugs
CT-P27
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on KCT0002211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002211.